Rhinosinusitis Clinical Trial
Official title:
Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery
The aim of this study is to determine what the ideal frequency of high-volume sinonasal saline irrigation in the early postoperative period following ESS for medically refractory CRS. We will evaluate once, twice, and three times daily frequency sinonasal saline irrigation protocols. Our hypothesis is that three times a day sinonasal saline irrigations for the first week is ideal with no difference between frequencies after 1 week.
Chronic Rhinosinusitis (CRS) is a common inflammatory condition of the upper respiratory
tract lasting more than 8 to 12 weeks. Major symptoms include facial congestion/fullness,
facial pain/pressure, nasal obstruction/blockage, purulent nasal drainage, and reduction or
loss of smell. The diagnosis must include two major symptoms and either endoscopic evidence
of polyps, edema or mucopurulent discharge from the middle meatus and/or CT changes in the
mucosa of sinuses or ostiomeatal complexes.
CRS has an estimated prevalence of 5% in the Canadian population, and up to 16% in some
adult populations in the United States. Sinusitis is associated with a major societal health
care burden, costing billions of dollars a year in North America. The medical treatment of
CRS includes topical saline and corticosteroid sprays, systemic steroids and antimicrobials.
Specifically, sinonasal saline irrigation is a safe, nonpharmacologic treatment, and an
important and efficacious component in the management of CRS. Sinonasal saline irrigation
can vary by concentration (e.g. hypertonic, isotonic, hypotonic), pressure (e.g. passive or
active), and volume (e.g. high and low).
A recent evidence-based review by Rudmik et al. recommended sinonasal saline irrigation in
the early postoperative period following endoscopic sinus surgery. Although 'daily'
sinonasal saline irrigations are recommended, the ideal frequency is unknown since there
have been no studies evaluating this topic.
This is a prospective, randomized, single blind study evaluating the subjective and
objective outcomes of different sinonasal saline irrigation frequencies in patients who
receive ESS for medically refractory CRS. Both disease-specific quality of life (QoL) and
endoscopy scores will be measured at 1 week, 3 weeks, and 2 months postoperatively. The
expected total number of patients to be enrolled in this study is approximately 75 (25 per
arm), with a planned completion time of two years.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02636790 -
Early Versus Late Surgical Wait Times
|
Early Phase 1 | |
Completed |
NCT02712502 -
Levofloxacin in Bacterial Rhinosinussitis
|
N/A | |
Completed |
NCT00986830 -
Healthcare Utilization and Outcomes of FinESS Treatment in the Office
|
N/A | |
Completed |
NCT00534079 -
Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
|
Phase 3 | |
Completed |
NCT05442606 -
Physiotherapy Protocol in Treating Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT01955980 -
Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis
|
Phase 1/Phase 2 | |
Completed |
NCT04123405 -
Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis
|
Phase 3 | |
Completed |
NCT00797004 -
Olfactory Dysfunction of Rhinosinusitis
|
N/A | |
Recruiting |
NCT05494346 -
Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction
|
N/A | |
Not yet recruiting |
NCT05836935 -
Role of Imaging in Complications of Sinusitis
|
N/A | |
Withdrawn |
NCT02097576 -
Manuka Honey Nasal Rinse Study
|
N/A | |
Completed |
NCT01132781 -
Theophylline in Rhinitis
|
Phase 2 | |
Recruiting |
NCT00948519 -
Laser Assisted Treatment of Chronic Sinusitis With and Without Light Activated Agents
|
N/A | |
Completed |
NCT00554190 -
Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel
|
Phase 4 | |
Recruiting |
NCT03729258 -
Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.
|
Phase 3 | |
Withdrawn |
NCT03729310 -
Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis
|
Early Phase 1 | |
Recruiting |
NCT01296919 -
The Clinical Significance of the Uncinate Process Histopathology in Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT01086839 -
Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT00849953 -
FinESS Registry Study
|
N/A | |
Withdrawn |
NCT00669799 -
Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study
|
N/A |